F q u g i t a t i o n (R) of g a s t r i c contents is presmsd t o cause apnea i n sene infants. The m h a n i s m of such apnea is unclear and polygraphic d c a m n t a t i o n is lacking. W e recorded nasal a i rflaw ( f l m t e r ) , atdominal m v e m t s , o r a l C02 and EKG i n 13 infants. Group A (9 preterm infants, age 2-4 wk and 1 tern, age 1 wk) had a history of idiopathic prolonged apnea and ordinary post-feeding R episodes ("spitting up"); Group B (3 term infants, age 3 m) had R only. R episcdes were recorded i n a l l infants (43 episodes i n Group A and 10 i n Group B). In 37 of 53 R episodes pharyngeal pressure and pH were recorded t o aid i n detect i o n of R. In Group A m s t R episodes (92%) were m i a t e l y follaved by e i t h e r a short apnea (S-apnea = absent airflaw >3 sec) o r prolonged apnea (P-apnea = absent a i r f l m f o r >20 sGc o r absent flaw with heart r a t e 3 0 0 o r cyanosis). Althouqh mst of the 100 P-apneas recorded i n Group A were unrelated to R episodes, 8 P-apneas (occurring i n 4 preterm infants) coincided with R (a s t a t i s t i c a l l y significant association i n 3 infants: p<.01, p<.05, p<.05). A l l Group A infants had S o r P-apnea, o r b t h , during R. There were m S o r P-apneas during R i n Group B. &st P-apnea (83%) a d S-apnea (78%) consisted of obstructive inspiratory e f f o r t s o r breathing pauses ccanbined w i t h obstruction. We conclude: 1) regurgitation has l i t t l e e f f e c t on breathing i n healthy term infants but often causes S-apnea and, occasionally, P-apnea i n infants with a past history of apnea; and 2) the m hanism of t h i s apnea invulves b t h airway obstruction and respira- Gas was c o n t i n u a l l y sampled from 1.0 cm beyond t h e p l a s t i c adapt e r o f an o r a l ET tube v i a a c a t h e t e r w i t h i n n e r diameter 0.38 mn. 9 neonates (mean B W 21829, range 870-3440; mean GA 33.8 wk, range 26-40) w i t h cardiopulmonary diseases ( 5 HMD, 2 a s p i r a t i o n , 1 each PDA, CHD, BPD, pneumothorax) were s t u d i e d a t an i n i t i a l mean age o f 82 h r s (619 < 72 hrs). 75 p a i r e d comparisons of PECO~ and paCO2 had a c o r r e l a t i o n o f 0.69 (p < 0.001) and a mean g r a d i e n t (paC02-PECO~) o f 8.3 t o r r (range +23 t o -3). 61.3% o f t h e g r a d i e n t s were < 10 t o r r . W e conclude t h a t t h e MS i s a usef u l m o n i t o r i n g device b u t t h a t t h e c o r r e l a t i o n between paC02 and PECO~ was adversely a f f e c t e d by the r e l a t i v e l y long response time o f t h e t o t a l system. We speculate t h a t r e d u c t i o n o f t h i s parameter would enhance t h e usefulness o f the MS by i n c r e a s i n g t h e c o r r e l a t i o n and decreasing t h e g r a d i e n t . To determine whethe; serum iim;recbmp~ex formation occu;s following intratracheal instillation of exogenous human surfactant in infants with severe RDS, an ELlSA assay for surfactant-antisurfactant immune complexes was developed using rabbit anti-human surfactant antibodies followed by horseradish-peroxidase ant+ human lg. Anti-surfactant antibody formation during the first 3 months following surfactant instillation was measured 6 C50 & C3 levels & urinalysis were performed to determine whether the classical pathway was activated. Seven infants receiving exogenous human surfactant & 1 1 infants with severe RDS receiving only intermittent mandatory ventilation (IMV) were compared. Serum surfactant-anti-surfactant immune complex formation was detected shortly after surfactant instillation & peaked in concentration (0.0.490) 7 days after treatment versus a peak in surfectant-anti -surfactant immune complex format ion 12 days after birth in infants with severe RDS receiving only IMV. Complexes could be detected for 2 months following surfactant admirr istration & for 25 days in IMV treated infants. C50 levels in surfactant treated infants was 90 * 15 vs. 105 * 22 U/ml & C3 levels were similar in both groups & urinalysis did not reveal proteinuria. Although some variation in time course & peaks was observed, a consistent pattern of surfactant-anti-surfactant complexes was found in infants with RDS. These findings underscore the need for caution in administration of xenogenic biologically active substances to human infants. 
High frequency o s c i l l a t i o n (HFO) appears t o be an a l t e r n a t e , l e s s t r a u m a t i c mode o f v e n t i l a t i n g s u r f a c t a n t d e f i c i e n t p a t i e n t s .
Conventional mechanical pressure l i m i t e d v e n t i l a t i o n (CMV) i s known t o compromise cardiac f u n c t i o n a t high mean airway pressures. Our o b j e c t i v e was t o compare systemic cardiac o u t p u t and i t s d i s t r i b u t i o n u s i n g these two modes o f v e n t i l a t i o n . We studied t e n a d u l t r a b b i t s rendered s u r f a c t a n t d e f i c i e n t by pulmonary s a l i n e lavage and a l t e r n a t e d on both modes o f v e n t i l a t i o n . ;;::ii4 ( a l l data as mean+SEll) kidneys 1 9 4~2 0 A t s i m i l a r mean airway pressures t h e r e i s no d i f f e r e n c e i n systemic cardiac o u t p u t from CMV t o HFO. Furthermore t h i s study found no evidence o f organ ischemia d u r i n g HFO. Hypoplasia of the fetal lungs (L.H.) is found in association with long standing oligohydramnios. In the animal model, interference with fetal breathing (F.B.) activity by phrenectomy or curarization has led to lung hypoplasia. It has been suggested that L.H. associated with oligohydramnios is due to inhibition of F.B.
Four patients with oligohydramnios (2 intact membranes, 2 prolonged rupture) were studied in a total of eleven 60-minute sessions from 27-38 weeks. F.B. and other fetal movements (OFM) were recorded using linear array sonography, For each patient study session a gestationa1,age matched control with normal amniotic fluid volume was studied. Three of the four study subjects had fetal lung hypoplasia. No difference in other Om? was noted.
From these preliminary observations we conclude that FB does occur in cases of oligohydramnios associated with lung hypoplasia. It is therefore unlikely that lung hypoplasia is merely the result of absent FB. We s t u d i e d 56 normal i n f a n t s (NL) and 16 i n f a n t s w i t h bronchopulmonary dysplasia (BPD) t o determine a l t e r a t i o n s i n T I and SG w i t h growth i n h e a l t h and disease. T I was measured a t 6 and 10 Hz by a standard f o r c e d o s c i l l a t i o n technique. Functional r e s i d u a l c a p a c i t y (FRC) was measured by helium d i l u t i o n technique. The ages, FRCs, and l e n g t h s (L) were n o t d i f f e r e n t between groups. I n both groups t h e r e was a s i g n i f i c a n t decrease i n T I w i t h i n c r e a s i n g s i z e (NL: r=-.53, p<.001; BPD: r=.54, p<.02). The mean T I values were s i g n i f i c a n t l y h i g h e r f o r t h e BPD group: Normal TI-6Hz 3 4 . 4 5 * 4 6 . 8 7 6 . 9 BPD * , , an ? SE TI-1OHz 27.6 + 1.0 34.2 ? 3.9 < .05 T I a t lOHz was s i g n i f i c a n t l y lower i n both groups thac T I a t 6Hz (p<.001). SG a l s o decreased w i t h growth d e s p i t e t h e decrease i n T I (NL: r=-.50, p<.001; BPO: r=-.38, p<.10). There was no d i f f e r e n c e i n SG between groups. We conclude t h a t T I i s e a s i l y measured i n i n f a n t s by f o r c e d o s c i l l a t i o n and demonstrates t h e expected decrease w i t h growth and a frequency dependence. F i n a l l y , SG decreases w i t h growth suggesting a r e l a t i v e dysanapsis i n l u n g growth w i t h l u n g volume i n c r e a s i n g more r a p i d l y than airway size. (Supported by NHLBI SCOR Grant # 14136)
